BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22694239)

  • 1. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention.
    White JM; Mimiaga MJ; Krakower DS; Mayer KH
    AIDS Patient Care STDS; 2012 Jul; 26(7):395-405. PubMed ID: 22694239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts.
    Mimiaga MJ; White JM; Krakower DS; Biello KB; Mayer KH
    AIDS Care; 2014; 26(6):684-93. PubMed ID: 24116985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness, knowledge, and attitudes related to HIV pre-exposure prophylaxis and other prevention strategies among physicians from Brazil and Mexico: cross-sectional web-based survey.
    Vega-Ramirez H; Torres TS; Guillen-Diaz C; Pimenta C; Diaz-Sosa D; Konda KA; da Cunha ARC; Robles-Garcia R; Benedetti M; Hoagland B; Bezerra DRB; Caceres CF; Grinsztejn B; Veloso VG;
    BMC Health Serv Res; 2022 Apr; 22(1):532. PubMed ID: 35459177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices.
    Tellalian D; Maznavi K; Bredeek UF; Hardy WD
    AIDS Patient Care STDS; 2013 Oct; 27(10):553-9. PubMed ID: 24053478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection.
    Di Biagio A; Riccardi N; Signori A; Maserati R; Nozza S; Gori A; Bonora S; Borderi M; Ripamonti D; Rossi MC; Orofino G; Quirino T; Nunnari G; Celesia BM; Martini S; Sagnelli C; Mazzola G; Colletti P; Bartolozzi D; Bini T; Ladisa N; Castelnuovo F; Saracino A; Lo Caputo S
    PLoS One; 2017; 12(7):e0181433. PubMed ID: 28727818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' preparedness for pre-exposure prophylaxis: results of an online survey in Belgium.
    Reyniers T; Vuylsteke B; Pirotte B; Hoornenborg E; Bil JP; Wouters K; Laga M; Nöstlinger C
    Sex Health; 2018 Nov; 15(6):606-611. PubMed ID: 30384876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitude towards antiretroviral Pre-Exposure Prophylaxis (PrEP) prescription among HIV specialists.
    Puro V; Palummieri A; De Carli G; Piselli P; Ippolito G
    BMC Infect Dis; 2013 May; 13():217. PubMed ID: 23672424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.
    Palummieri A; De Carli G; Rosenthal É; Cacoub P; Mussini C; Puro V;
    BMC Infect Dis; 2017 Nov; 17(1):734. PubMed ID: 29179700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015.
    Smith DK; Mendoza MC; Stryker JE; Rose CE
    PLoS One; 2016; 11(6):e0156592. PubMed ID: 27258374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitude of infectious diseases physicians in Turkey about HIV pre-exposure prophylaxis: results of an online survey.
    Cimen C; Emecen AN; Barber TJ
    Int J STD AIDS; 2020 Jun; 31(7):665-670. PubMed ID: 32538328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Influencing Clinicians' Willingness to Prescribe Pre-exposure Prophylaxis for Persons at High Risk of HIV in China: Cross-sectional Online Survey Study.
    Cui S; Ding H; Huang X; Wang H; Tang W; Leuba SI; Ye Z; Jiang Y; Geng W; Xu J; Shang H
    JMIR Public Health Surveill; 2021 Jun; 7(6):e24235. PubMed ID: 34085941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Care providers' knowledge and willingness to prescribe pre-exposure prophylaxis (PrEP) in Kinshasa, Democratic Republic of Congo (DRC)].
    Bepouka BI; Situakibanza H; Kokusa Y; Nkodila A; Kizunga F; Kiazayawoko F
    Pan Afr Med J; 2019; 34():166. PubMed ID: 32153706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England.
    Krakower DS; Oldenburg CE; Mitty JA; Wilson IB; Kurth AE; Maloney KM; Gallagher D; Mayer KH
    PLoS One; 2015; 10(7):e0132398. PubMed ID: 26146824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR; Kiser PF
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.
    Mullins TLK; Zimet G; Lally M; Xu J; Thornton S; Kahn JA
    AIDS Patient Care STDS; 2017 Dec; 31(12):504-516. PubMed ID: 29211514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-exposure prophylaxis and antiretroviral resistance: HIV prevention at a cost?
    Hurt CB; Eron JJ; Cohen MS
    Clin Infect Dis; 2011 Dec; 53(12):1265-70. PubMed ID: 21976467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes and Knowledge About Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Brazilian Infectious Disease Physicians.
    Cerqueira NB; Vasconcelos R; Hojilla JC; Kallás EG; Avelino-Silva VI
    AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1047-1053. PubMed ID: 32657136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes towards, knowledge about, and confidence to prescribe antiretroviral pre-exposure prophylaxis among healthcare providers in Thailand.
    Wisutep P; Sirijatuphat R; Navanukroh O; Phatharodom P; Werarak P; Rattanasuwan W
    Medicine (Baltimore); 2021 Dec; 100(49):e28120. PubMed ID: 34889271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health.
    Okoro O; Hillman L
    J Am Pharm Assoc (2003); 2018; 58(4):412-420.e3. PubMed ID: 29789257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians.
    Blackstock OJ; Moore BA; Berkenblit GV; Calabrese SK; Cunningham CO; Fiellin DA; Patel VV; Phillips KA; Tetrault JM; Shah M; Edelman EJ
    J Gen Intern Med; 2017 Jan; 32(1):62-70. PubMed ID: 27778215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.